Evidence map›Paper›PMID 22318627›Full record

ArticleDevelopment (Cambridge, England)2012

Musculin and TCF21 coordinate the maintenance of myogenic regulatory factor expression levels during mouse craniofacial development.

Natalia Moncaut, Joe W Cross, Christine Siligan, Annette Keith, Kevin Taylor, Peter W J Rigby, Jaime J Carvajal

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multiple Cell Lineages Give Rise to a Cell Type.Results and problems in cell differentiation · 2024
    Article
  5. Article
  6. Gαi2 regulates the adult myogenesis of masticatory muscle satellite cells.Journal of cellular and molecular medicine · 2023
    Article
  7. Article
  8. The impact of Drew Noden's work on our understanding of craniofacial musculoskeletal integration.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. TCF21: a critical transcription factor in health and cancer.Journal of molecular medicine (Berlin, Germany) · 2020
    Review
  15. Article
  16. Review
  17. Review
  18. Master control: transcriptional regulation of mammalian Myod.Journal of muscle research and cell motility · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Natalia MoncautDivision of Cancer Biology, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, UK.
Joe W Cross
Christine Siligan
Annette Keith
Kevin Taylor
Peter W J Rigby
Jaime J Carvajal
Institute of Cancer Research · GB

Funding

Medical Research Council G040119Medical Research Council G0401199
6 · The paper itself

Abstract

The specification of the skeletal muscle lineage during craniofacial development is dependent on the activity of MYF5 and MYOD, two members of the myogenic regulatory factor family. In the absence of MYF5 or MYOD there is not an overt muscle phenotype, whereas in the double Myf5;MyoD knockout branchiomeric myogenic precursors fail to be specified and skeletal muscle is not formed. The transcriptional regulation of Myf5 is controlled by a multitude of regulatory elements acting at different times and anatomical locations, with at least five operating in the branchial arches. By contrast, only two enhancers have been implicated in the regulation of MyoD. In this work, we characterize an enhancer element that drives Myf5 expression in the branchial arches from 9.5 days post-coitum and show that its activity in the context of the entire locus is dependent on two highly conserved E-boxes. These binding sites are required in a subset of Myf5-expressing cells including both progenitors and those which have entered the myogenic pathway. The correct levels of expression of Myf5 and MyoD result from activation by musculin and TCF21 through direct binding to specific enhancers. Consistent with this, we show that in the absence of musculin the timing of activation of Myf5 and MyoD is not affected but the expression levels are significantly reduced. Importantly, normal levels of Myf5 expression are restored at later stages, which might explain the absence of particular muscles in the Msc;Tcf21 double-knockout mice.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsBase SequenceBasic Helix-Loop-Helix ProteinsBody PatterningBranchial RegionEmbryo, MammalianGene Regulatory NetworksHumansMiceMice, KnockoutMolecular Sequence DataMuscle, SkeletalMutationMyoD ProteinMyogenic Regulatory Factor 5Basic Helix-Loop-Helix ProteinsMsc protein, mouseMyoD ProteinMyogenic Regulatory Factor 5T-Box Domain ProteinsTbx1 protein, mouseTcf21 protein, mouseTranscription Factors

Identifiers

PMID22318627
PMCPMC3274357
OpenAlexW1970378018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.